Literature DB >> 13947966

The initial clinical trial of nitrogen mustard.

A GILMAN.   

Abstract

Entities:  

Keywords:  MECHLORETHAMINE

Mesh：

Substances：

Year:  1963        PMID： 13947966     DOI： 10.1016/0002-9610(63)90232-0

Source DB:  PubMed          Journal:  Am J Surg        ISSN： 0002-9610            Impact factor:   2.565


× No keyword cloud information.
  54 in total

Review 1.  Evolution of acquired resistance to anti-cancer therapy.

Authors:  Jasmine Foo; Franziska Michor
Journal:  J Theor Biol       Date:  2014-03-25       Impact factor: 2.691

2.  Cancer pharmacotherapy: 21st century 'magic bullets' and changing paradigms.

Authors:  L D Lewis
Journal:  Br J Clin Pharmacol       Date:  2006-07       Impact factor: 4.335

Review 3.  Evolving concepts in cancer therapy through targeting sphingolipid metabolism.

Authors:  Jean-Philip Truman; Mónica García-Barros; Lina M Obeid; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2013-12-30

4.  Breast cancer in the 20 century: quest for the ideal therapy.

Authors:  P Borgen
Journal:  Ochsner J       Date:  2000-01

Review 5.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

6.  Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells.

Authors:  K B Tan; M R Mattern; R A Boyce; P S Schein
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

Review 7.  Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites.

Authors:  T Kerbusch; J de Kraker; H J Keizer; J W van Putten; H J Groen; R L Jansen; J H Schellens; J H Beijnen
Journal:  Clin Pharmacokinet       Date:  2001-01       Impact factor: 6.447

Review 8.  Early-Phase Platform Trials: A New Paradigm for Dose Finding and Treatment Screening in the Era of Precision Oncology.

Authors:  Mei-Yin C Polley; Ying Kuen Cheung
Journal:  JCO Precis Oncol       Date:  2019-10-24

Review 9.  Tumor models in drug development.

Authors:  D P Griswold; S D Harrison
Journal:  Cancer Metastasis Rev       Date:  1991-10       Impact factor: 9.264

10.  pH-responsive hydrogels containing PMMA nanoparticles: an analysis of controlled release of a chemotherapeutic conjugate and transport properties.

Authors:  Cody A Schoener; Nicholas A Peppas
Journal:  J Biomater Sci Polym Ed       Date:  2012-10-15       Impact factor: 3.517
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.